Table 2 Biological and immunological thyroid status.
From: Prevalence and impact of thyroid dysfunction in patients with rheumatoid arthritis
Biological data: | RA group | Control group | p-value | Reference values |
|---|---|---|---|---|
FT4 (pmol/L) | 15.01 [13.48;16.71] | 15.4 [13.87;16.66] | 0.362 | 12–22 |
TSH (mUI/L) | 1.42 [0.91;2.26] | 1,79 [1.25;2.26] | 0.152 | 0.27–4.2 |
TPOAb (UI/mL) | 12.80 [8.98–16.43] | 6.81 [5.19–9.17] | < 0.01 | 0–34 |
TgAb (UI/mL) | 16.49 [13.32–21.31] | 10.36 [10–12.53] | < 0.01 | 0–115 |
TRAb (UI/L) | 0.9 [0.8–2.7] | 0.83 [0.8–2.01] | 0.02 | < 1.75 |
Positive TPOAb (n (%)) | 6 (10.3) | 5 (9) | 0.751 | |
Positive TgAb (n (%)) | 3 (5.2) | 3 (5) | 1.000 | |
Positive TRAb (n (%)) | 2 (3.4) | 1 (2) | 0.500 | |
Thyroid status | ||||
Thyroid dysfunction (n (%)) | 11 (19) | 3 (5) | < 0.01 | |
Hypothyroidism (n (%)) * | 10 (17) | 3 (5) | 0.013 | |
Hyperthyroidism (n (%)) | 1 (2) | 0 (0) | 1.000 | |
Autoimmune thyroid disease (n (%)) | 9 (15.5) | 7 (12) | 0.590 | |